England, Elizabeth
Rees, D. Gareth
Scott, Ian Christopher
Carmen, Sara
Chan, Denice T. Y.
Chaillan Huntington, Catherine E.
Houslay, Kirsty F.
Erngren, Teodor
Penney, Mark
Majithiya, Jayesh B.
Rapley, Laura
Sims, Dorothy A.
Hollins, Claire
Hinchy, Elizabeth C.
Strain, Martin D.
Kemp, Benjamin P.
Corkill, Dominic J.
May, Richard D.
Vousden, Katherine A.
Butler, Robin J.
Mustelin, Tomas
Vaughan, Tristan J.
Lowe, David C.
Colley, Caroline
Cohen, E. Suzanne
Funding for this research was provided by:
AstraZeneca
Article History
Received: 28 February 2023
Accepted: 7 June 2023
First Online: 17 June 2023
Competing interests
: AstraZeneca funded this study and participated in the study design, data collection, data analysis and data interpretation. AstraZeneca reviewed the publication, without influencing the opinions of the authors, to ensure medical and scientific accuracy and the protection of intellectual property. The corresponding author had access to all data in the study and was responsible for submitting the manuscript for publication. E.E., D.G.R., I.C.S., S.C., C.C., D.J.C., K.F.H., C.C.E.H., D.A.S., C.H., E.C.H., M.D.S., E.S.C., T.J.V., T.E. and M.P. are employees of AstraZeneca and may hold stock or stock options. D.T.Y.C., B.P.K., D.C.L., J.B.M., R.D.M., L.R., K.A.V., R.J.B. and T.M. are former employees of AstraZeneca and may hold stock or stock options.